Gillette conducts research in medical issues. In our James R. Gage Center for Gait and Motion Analysis, we’re conducting an ongoing study to measure how interventions patients received as children have affected them as adults. The results could influence the care of children throughout the world who have gait difficulties.

Gillette played a key role in the clinical trials and breakthrough research for the development of Spinraza™ (nusinersen) a drug to treat spinal muscular atrophy (SMA). The drug was recently approved by the FDA, making it the first-ever FDA-approved therapy for SMA.

Gillette is the Children’s Miracle Network Hospital® for Minnesota and western Wisconsin. This support from Children’s Miracle Network Hospitals® allows us to offer state-of-the-art treatments and vital services for kids with the most complex needs in pediatric medicine and funds care for patients who are uninsured or underinsured. Your donations ensure that Gillette will never turn a child away because of a family’s inability to pay for treatment. Children’s Miracle Network raises funds for 170 children’s hospitals across North America. Those hospitals, in turn, use the money where it’s needed most. Donations stay in the community where they are made, ensuring that every dollar helps local kids.

In Minnesota and western Wisconsin, donations to Children’s Miracle Network Hospitals fund life-changing care for children served by Gillette.